A Comprehensive Cardiac Rehabilitation Program in Post-CABG Patients: A Rationale and Critical Pathway

Critical Pathways in Cardiology

Volumn 2, Issue 1, 2003, Pages 20-33

  Sethi, Prabhdeep S ^a   Nance, James ^a   Johnson, Dan ^a   Wilke, Jon ^a   Wilson, Kent ^a   Hall, Robert ^a   Romero Vagedes, Florinda ^a   Wilson, Christine ^a   Jones, William ^a   Dye, Deborah ^a   Dzurick, Julie ^a   Ohm, Janet ^a   Ericson, Paula ^a   Wendel, Christopher ^b   Mohler, Jane ^b   Dahiya, Ranjan ^a   Dick, Edward ^a   Thai, Hoang ^a   Goldman, Steven ^a   Rhenman, Birger ^a   Morrison, Douglass A ^a   more..

^a UNIVERSITY OF ARIZONA   (United States)

^b Cardiac Catheterization Laboratories ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; TRIACYLGLYCEROL;

ANAMNESIS; ANTHROPOMETRY; ATHEROSCLEROSIS; BEHAVIOR; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL PATHWAY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEPRESSION; DYSLIPIDEMIA; EXERCISE TEST; FLUSHING; FOLLOW UP; HEALTH PROGRAM; HEART MUSCLE ISCHEMIA; HEART REHABILITATION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; KINESIOTHERAPY; LABORATORY TEST; LIFESTYLE; MEDICAL ASSESSMENT; MENTAL STRESS; MOBILIZATION; MOTIVATION; OBESITY; OUTPATIENT; PATIENT MONITORING; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; RHABDOMYOLYSIS; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SMOKING; SOCIAL PSYCHOLOGY; SURGICAL PATIENT; SYMPTOM; TREADMILL; TREATMENT CONTRAINDICATION; WELLBEING;

EID: 0345686496     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HPC.0000057391.93352.AA     Document Type: Review

References (51)

1. Pearson T, Rapaport E, Criqui M, et al. Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association writing group. Circulation 1994;90:3125-33.
2. Ades PA, Huang D, Weaver SO. Cardiac rehabilitation participation predicts lower rehospitalization costs. Am Heart J 1992;123:916-21.
3. Hedback BE, Perk J, Engvall J, et al. Cardiac rehabilitation after coronary artery bypass grafting: effects on exercise performance and risk factors. Arch Phys Med Rehabil 1990;71:1069-73.
4. Hoad NA, Crawford IC. Rehabilitation after coronary artery bypass grafting and improved quality of life. Br J Sports Med 1990;24:120-2.
5. Franklin B, Bonzheim K, Warren J, et al. Effects of a contemporary, exercise-based rehabilitation and cardiovascular risk-reduction program on coronary patients with abnormal baseline risk factors. Chest 2002;122:338-43.
6. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990;336:129-33.
7. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89:978-90.
8. Stock MC, Downs JB, Gauer PK, et al. Prevention of postoperative pulmonary complications with CPAP, incentive spirometry, and conservative therapy. Chest 1985;87:151-7.
9. Franklin B, Bonzheim K, Gordon S, et al. Safety of medically supervised outpatient cardiac rehabilitation exercise therapy: A 16-year follow-up. Chest 1998;114:902-6.
10. Wilson K, Gibson N, Willan A, et al. Effect of smoking cessation on mortality after myocardial infarction: Meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44.
11. Cavender JB, Robers WJ, Fisher LD, et al. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study: 10-year follow-up. J Am Coll Cardiol 1992;20:287-94.
12. Wilhelmsson C, Vedin JA, Elmfeldt D, et al. Smoking and myocardial infarction. Lancet 1975;1:415-20.
13. Hajek P, Taylor TZ, Mills P. Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: Randomized controlled trial. BMJ 2002;324:87-9.
14. Taylor CB, Houston-Miller N, Killen JD, et al. Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Ann Intern Med 1990;113:118-23.
15. Fragnoli-Munn K, Savage PD, Ades PA. Combined resistive-aerobic training in older patients with coronary artery disease early after myocardial infarction. J Cardiopulm Rehabil 1998;18:416-20.
16. Ades, PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001;345:892-902.
17. Anderson KM, Castelli WP, et al. Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA 1987;257:2176-80.
18. Campeau L, Enjalbert M, Lespe'rance J, et al. The relation of risk factors to the development of atherosclerosis to saphenous-vein grafts and the progression of disease in the native circulation. A study 10 years after aorto-coronary bypass surgery. N Engl J Med 1984;311:1329-32.
19. Blankenhorn D, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy or coronary therosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233-40.
20. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
21. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
22. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
23. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
24. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81:7B-12B
25. Senaratne MPJ, Griffiths J, Mooney D, et al. Effectiveness of a planned strategy using cardiac rehabilitation nurses for the management of dyslipidemia in patients with coronary artery disease. Am Heart J 2001;142:975-81.
26. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
27. Ades PA, Grunvald MH, Weiss RM, et al. Usefulness of myocardial ischemia as predictor of training effect in cardiac rehabilitation after acute myocardial infarction or coronary artery bypass grafting. Am J Cardiol 1989;63:1032-6.
28. Milani RV, Lavie CJ, Casisdy MM. Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J 1996;132:723-32.
29. Dracup K, Mose DK, Marsden C, et al. Effects of a multidimensional cardiopulmonary rehabilitation program on psychosocial function. Am J Cardiol 1991;68:31-4.
30. Ahern DK, Gorkin L, Anderson JL, et al. Biobehavioral variables and mortality or cardiac arrest in the CAPS (Cardiac Arrhythmia Pilot Study). Am J Cardiol 1990;66:59-62.
31. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. JAMA 1993;270:1819-25.
32. Stern MJ, Pascale L, Ackerman A. Life adjustment post-myocardial infarction: determining predictive variables. Arch Intern Med 1977;137:1680-5.
33. Byrne A, Byrne DG. The effect of exercise on depression, anxiety and other mood states: A review. J Psychosom Res 1993;37:565-74.
34. Engblom E, Korpilahti K, Hamalainen H, et al. Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation. J Cardiopulm Rehabil 1997;17:29-36.
35. Eckel RH. Obesity and heart disease: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997;96:3248-50.
36. Krauss RM, Winston M, Fletcher BJ, et al. Obesity: Impact on cardiovascular disease. Circulation 1998;98:1472-6.
37. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85.
38. Schulte H, Cullen P, Assmann G. Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM). Atherosclerosis 1999;144:199-209.
39. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
40. Grundy SM, Barnett JP. Metabolic and health complications of obesity. Dis Mon 1990;36:641-731.
41. Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-11.
42. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;282:1519-22.
43. 27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events. September 14-15, 1995. J Am Coll Cardiol 1996;27:957-1046.
44. Williamson DF, Pamuk E, Thun M, et al. Prospective study of intentional weight-loss and mortality in never-smoking overweight US white women aged 40-64. Am J Epidemiol 1995;141:1128-41.
45. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8.
46. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992;16:397-415.
47. Apfelbaum M, Vague P, Ziegler O, et al. Long-term maintenance of weight loss after a very-low-calorie diet: Efficacy and tolerability of sibutramine. Am J Med 1999;106:179-84.
48. McKay RH. Long-term use of diethylpropion in obesity. Curr Med Res Opin 1973;1:489-93.
49. Wirth A, Krause J. Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001;286:1331-9.
50. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trial. JAMA 1999;281:235-42.
51. Camacho TC, Roberts RE, Lazarus NB, et al. Physical activity and depression: Evidence from the Alameda County Study. Am J Epidemiol 1991;134:220-31.